|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.62 EUR | -1.19% |
|
+5.42% | +27.52% |
| 03-13 | STMicroelectronics Forecasts Revised as AlphaValue/Baader Europe Notes FY27 Revenue Potential | MT |
| 03-13 | Diary - France corporate earnings week ahead | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 9.95 | 15.6 | 13 | 4.2 | 1.25 | |||||
Return on Total Capital | 12.79 | 20.01 | 16.19 | 5.05 | 1.5 | |||||
Return On Equity % | 22.57 | 36 | 28.52 | 9.06 | 1 | |||||
Return on Common Equity | 22.65 | 36.16 | 28.62 | 9.11 | 0.94 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 41.69 | 47.33 | 48.04 | 39.34 | 33.89 | |||||
SG&A Margin | 10.45 | 9.08 | 9.55 | 12.54 | 13.99 | |||||
EBITDA Margin % | 26.9 | 35.02 | 35.77 | 25.71 | 19.92 | |||||
EBITA Margin % | 19.44 | 28.12 | 27.31 | 13.22 | 5.06 | |||||
EBIT Margin % | 18.71 | 27.48 | 26.74 | 12.45 | 4.2 | |||||
Income From Continuing Operations Margin % | 15.72 | 24.59 | 24.42 | 11.79 | 1.53 | |||||
Net Income Margin % | 15.67 | 24.55 | 24.36 | 11.73 | 1.41 | |||||
Net Avail. For Common Margin % | 15.67 | 24.55 | 24.36 | 11.73 | 1.41 | |||||
Normalized Net Income Margin | 11.33 | 17.42 | 17.29 | 8.77 | 3.93 | |||||
Levered Free Cash Flow Margin | 7.29 | 2.86 | -2.75 | -5.81 | -3.45 | |||||
Unlevered Free Cash Flow Margin | 7.5 | 2.91 | -2.55 | -5.41 | -3.17 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.85 | 0.91 | 0.78 | 0.54 | 0.48 | |||||
Fixed Assets Turnover | 2.49 | 2.33 | 1.84 | 1.24 | 1.08 | |||||
Receivables Turnover (Average Receivables) | 7.9 | 8.63 | 9.32 | 7.6 | 6.73 | |||||
Inventory Turnover (Average Inventory) | 3.9 | 3.73 | 3.4 | 2.93 | 2.63 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.65 | 2.56 | 3.17 | 3.11 | 3.36 | |||||
Quick Ratio | 1.93 | 1.82 | 2.34 | 2.28 | 2.3 | |||||
Operating Cash Flow to Current Liabilities | 1.04 | 1.36 | 1.61 | 0.79 | 0.64 | |||||
Days Sales Outstanding (Average Receivables) | 46.22 | 42.31 | 39.18 | 48.18 | 54.25 | |||||
Days Outstanding Inventory (Average Inventory) | 93.52 | 97.86 | 107.3 | 124.86 | 138.73 | |||||
Average Days Payable Outstanding | 66.23 | 74.23 | 79.8 | 71.42 | 62.98 | |||||
Cash Conversion Cycle (Average Days) | 73.51 | 65.94 | 66.68 | 101.62 | 130 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 29.57 | 22.81 | 18.83 | 17.91 | 12.92 | |||||
Total Debt / Total Capital | 22.82 | 18.57 | 15.85 | 15.19 | 11.44 | |||||
LT Debt/Equity | 27.43 | 21.03 | 17.2 | 12.01 | 11 | |||||
Long-Term Debt / Total Capital | 21.17 | 17.12 | 14.47 | 10.18 | 9.74 | |||||
Total Liabilities / Total Assets | 40.33 | 36.15 | 31.08 | 28.55 | 26.51 | |||||
EBIT / Interest Expense | 56.86 | 340.92 | 84.05 | 19.44 | 9.02 | |||||
EBITDA / Interest Expense | 83.36 | 439.23 | 113.73 | 41.02 | 44.05 | |||||
(EBITDA - Capex) / Interest Expense | 39.79 | 167.85 | 33.02 | 4.69 | 5.67 | |||||
Total Debt / EBITDA | 0.78 | 0.51 | 0.51 | 0.91 | 0.97 | |||||
Net Debt / EBITDA | -0.22 | -0.28 | -0.47 | -0.87 | -1.06 | |||||
Total Debt / (EBITDA - Capex) | 1.64 | 1.33 | 1.75 | 7.94 | 7.54 | |||||
Net Debt / (EBITDA - Capex) | -0.46 | -0.74 | -1.6 | -7.56 | -8.23 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 24.88 | 26.38 | 7.18 | -23.24 | -11.07 | |||||
Gross Profit, 1 Yr. Growth % | 40.41 | 43.32 | 8.76 | -37.01 | -23.39 | |||||
EBITDA, 1 Yr. Growth % | 51.5 | 62.63 | 8.82 | -44.56 | -31.19 | |||||
EBITA, 1 Yr. Growth % | 74.47 | 79.89 | 3.28 | -62.6 | -66.02 | |||||
EBIT, 1 Yr. Growth % | 77.81 | 82.54 | 3.49 | -64.03 | -70.03 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 81.05 | 97.71 | 6.45 | -62.93 | -88.5 | |||||
Net Income, 1 Yr. Growth % | 80.83 | 98 | 6.34 | -63.03 | -89.34 | |||||
Normalized Net Income, 1 Yr. Growth % | 77.44 | 91.02 | 5.54 | -60.81 | -60.24 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 80 | 93.85 | 6.54 | -62.82 | -89.09 | |||||
Accounts Receivable, 1 Yr. Growth % | 20.07 | 12 | -12.13 | 1.04 | -0.23 | |||||
Inventory, 1 Yr. Growth % | 7.12 | 30.98 | 4.45 | 3.56 | 12.24 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 23.15 | 44.89 | 28.69 | 3.06 | 1.66 | |||||
Total Assets, 1 Yr. Growth % | 7.51 | 28.58 | 22.38 | 1.19 | 0.23 | |||||
Tangible Book Value, 1 Yr. Growth % | 10.23 | 41.77 | 33.93 | 4.7 | 2.24 | |||||
Common Equity, 1 Yr. Growth % | 9.01 | 37.83 | 31.8 | 4.3 | 2.17 | |||||
Cash From Operations, 1 Yr. Growth % | 46.2 | 70 | 15.19 | -50.52 | -27.42 | |||||
Capital Expenditures, 1 Yr. Growth % | 42.63 | 92.79 | 25.08 | -30.43 | -31.64 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 76.64 | -51.65 | -202.86 | 56.08 | -47.01 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 70.69 | -52.11 | -193.79 | 56.07 | -47.81 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 0 | 50 | 0 | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 15.56 | 25.63 | 16.39 | -9.3 | -17.38 | |||||
Gross Profit, 2 Yr. CAGR % | 19.97 | 41.93 | 24.87 | -17.31 | -30.53 | |||||
EBITDA, 2 Yr. CAGR % | 29.72 | 57.88 | 33.44 | -22.26 | -38.2 | |||||
EBITA, 2 Yr. CAGR % | 40.6 | 78.58 | 36.83 | -37.79 | -64.32 | |||||
EBIT, 2 Yr. CAGR % | 41.9 | 81.66 | 37.99 | -38.93 | -67.14 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 39.35 | 89.19 | 45.08 | -37.18 | -79.35 | |||||
Net Income, 2 Yr. CAGR % | 39.21 | 89.22 | 45.1 | -37.3 | -80.15 | |||||
Normalized Net Income, 2 Yr. CAGR % | 39.64 | 85.69 | 42.54 | -35.62 | -60.49 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 37.65 | 86.8 | 43.71 | -37.06 | -79.86 | |||||
Accounts Receivable, 2 Yr. CAGR % | 12.9 | 15.96 | -0.8 | -5.78 | 0.4 | |||||
Inventory, 2 Yr. CAGR % | 7.99 | 18.45 | 16.97 | 4 | 7.81 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 18.85 | 33.58 | 36.55 | 15.17 | 2.36 | |||||
Total Assets, 2 Yr. CAGR % | 14.43 | 17.58 | 25.44 | 11.28 | 0.71 | |||||
Tangible Book Value, 2 Yr. CAGR % | 13.36 | 25.01 | 37.79 | 18.41 | 3.46 | |||||
Common Equity, 2 Yr. CAGR % | 14.35 | 22.58 | 34.78 | 17.25 | 3.23 | |||||
Cash From Operations, 2 Yr. CAGR % | 27.95 | 57.65 | 39.93 | -24.5 | -40.07 | |||||
Capital Expenditures, 2 Yr. CAGR % | 24.48 | 65.83 | 55.32 | -6.72 | -31.04 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 279.77 | -6.35 | -29.04 | 32.34 | -9.17 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 212.02 | -8.42 | -32.58 | 26.76 | -9.87 | |||||
Dividend Per Share, 2 Yr. CAGR % | 19.52 | 0 | 22.47 | 22.47 | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 9.71 | 19.06 | 19.15 | 1.31 | -9.89 | |||||
Gross Profit, 3 Yr. CAGR % | 11.28 | 27.35 | 29.89 | -0.67 | -19.39 | |||||
EBITDA, 3 Yr. CAGR % | 16.04 | 40.42 | 39.75 | -0.59 | -25.33 | |||||
EBITA, 3 Yr. CAGR % | 19.06 | 53.45 | 49.17 | -11.39 | -49.12 | |||||
EBIT, 3 Yr. CAGR % | 19.31 | 55.18 | 50.99 | -12.05 | -51.8 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 15.76 | 56.59 | 56.19 | -7.94 | -64.33 | |||||
Net Income, 3 Yr. CAGR % | 15.83 | 56.56 | 56.15 | -8.01 | -65.26 | |||||
Normalized Net Income, 3 Yr. CAGR % | 18.21 | 55.9 | 54.21 | -7.51 | -45.14 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 15.28 | 54.29 | 54.91 | -8.43 | -64.91 | |||||
Accounts Receivable, 3 Yr. CAGR % | 11.26 | 12.6 | 5.72 | -0.19 | -3.96 | |||||
Inventory, 3 Yr. CAGR % | 7.96 | 15.17 | 13.59 | 12.32 | 6.68 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 15.07 | 26.96 | 31.93 | 24.33 | 10.48 | |||||
Total Assets, 3 Yr. CAGR % | 9.6 | 18.97 | 19.16 | 16.77 | 7.47 | |||||
Tangible Book Value, 3 Yr. CAGR % | 7.82 | 22.13 | 27.91 | 25.74 | 12.75 | |||||
Common Equity, 3 Yr. CAGR % | 9.25 | 21.69 | 25.58 | 23.74 | 11.99 | |||||
Cash From Operations, 3 Yr. CAGR % | 18.37 | 40.67 | 41.99 | -1.05 | -25.49 | |||||
Capital Expenditures, 3 Yr. CAGR % | 13.16 | 44.02 | 51.25 | 18.84 | -15.9 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 79.82 | 92.75 | -3.31 | -6.58 | -2.54 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 70.27 | 68.5 | -7.63 | -9.57 | -5.78 | |||||
Dividend Per Share, 3 Yr. CAGR % | 0 | 12.62 | 14.47 | 14.47 | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 12.85 | 14.08 | 12.33 | 6.79 | 2.92 | |||||
Gross Profit, 5 Yr. CAGR % | 16.69 | 18.46 | 16.55 | 7.15 | 1.08 | |||||
EBITDA, 5 Yr. CAGR % | 27.95 | 27.31 | 23 | 10.83 | 0.73 | |||||
EBITA, 5 Yr. CAGR % | 46.63 | 32.82 | 26.28 | 6.92 | -15.94 | |||||
EBIT, 5 Yr. CAGR % | 50.92 | 33.66 | 26.88 | 6.85 | -18.06 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 63.82 | 37.4 | 26.7 | 8.66 | -30.47 | |||||
Net Income, 5 Yr. CAGR % | 64.71 | 37.63 | 26.75 | 8.57 | -31.57 | |||||
Normalized Net Income, 5 Yr. CAGR % | 51.59 | 35.33 | 27.84 | 9.44 | -10.67 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 63.08 | 36.3 | 25.9 | 7.79 | -31.5 | |||||
Accounts Receivable, 5 Yr. CAGR % | 13.38 | 11.39 | 6.27 | 4.85 | 3.56 | |||||
Inventory, 5 Yr. CAGR % | 10.95 | 14.11 | 11.48 | 10.56 | 11.24 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 19.82 | 21.53 | 23.22 | 22.11 | 19.2 | |||||
Total Assets, 5 Yr. CAGR % | 11.37 | 15.6 | 15.68 | 15.83 | 11.4 | |||||
Tangible Book Value, 5 Yr. CAGR % | 11.48 | 18.78 | 18.94 | 20.63 | 17.51 | |||||
Common Equity, 5 Yr. CAGR % | 12.09 | 18.62 | 18.83 | 19.9 | 16.11 | |||||
Cash From Operations, 5 Yr. CAGR % | 24.02 | 25.41 | 26.57 | 9.67 | 0.56 | |||||
Capital Expenditures, 5 Yr. CAGR % | 24.53 | 22.08 | 28.58 | 21.2 | 10.47 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 13.1 | 35.23 | 24.36 | 64.23 | -5.01 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 12.63 | 46.51 | 17.91 | 48.87 | -7.77 | |||||
Dividend Per Share, 5 Yr. CAGR % | 0 | 0 | 8.45 | 16.47 | - |
- Stock Market
- Equities
- STMPA Stock
- Financials STMicroelectronics N.V.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















